Go to deals
Healthcare

Bioventix has completed a US$1.4 million sell-down of founder’s equity

Bioventix Plc has raised funds through a sell-down of the founder’s equity.

Bioventix was founded in 2003 as a biotechnology company specializing in the creation and supply of high-affinity sheep monoclonal antibodies (SMAs) for use in immunodiagnostics such as clinical blood testing.

Oaklins Cavendish’s sister firm finnCap, based in the UK, acted as financial advisor and broker in respect of the sell-down of the founder’s equity.

Service
Funding, debt advisory & ECM
Parties

Talk to the deal team

 Geoff  Nash

Geoff Nash

Partner

London, United Kingdom
Oaklins Cavendish

Related deals

Rotem Shani has completed an IPO
Real Estate

Rotem Shani has completed an IPO

Rotem Shani Ltd has completed an IPO to refinance and develop the company.

Learn more
Dutch Dental Group has raised new acquisition debt from ING Bank to support its growth strategy
Private Equity | Healthcare

Dutch Dental Group has raised new acquisition debt from ING Bank to support its growth strategy

Dutch Dental Group (DDG) has raised a new debt financing package provided by ING Bank, consisting of term loans, an acquisition facility and an RCF.

Learn more
Groupe Voie Lactée has been acquired by Initiative & Finance
Private Equity | Healthcare

Groupe Voie Lactée has been acquired by Initiative & Finance

JFC Industrie has sold Groupe Voie Lactée to Initiative & Finance.

Learn more